Skip to content
lifestyle.washingtonguardian.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Coultreon Biopharma BV
Final Safety, Pharmacokinetic and Pharmacodynamic Data from COL-5671 Phase 1 Clinical Study Presented at UEGW
October 19, 2026
Coultreon Biopharma Appoints Nate Massari as Chief Business Officer
September 14, 2026
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
August 18, 2026